BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/4/2018 3:36:40 AM | Browse: 1047 | Download: 1474
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 39386
Country Australia
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Systematic Reviews
Article Title Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?
Manuscript Source Unsolicited Manuscript
All Author List Rachel Chang Lee, Harsh Kanhere, Markus Trochsler, Vy Broadbridge, Guy Maddern and Timothy J Price
Funding Agency and Grant Number
Corresponding Author Timothy J Price, FRACP, MBBS, MD, Professor, Department of Medical Oncology, the Queen Elizabeth Hospital, 28 Woodville Road, Adelaide 5011, Australia. timothy.price@adelaide.edu.au
Key Words Pancreas; Liver resection; Gall bladder; Cholangiocarcinoma; Review
Core Tip Hepatic resection may be feasible for highly selected pancreatic and biliary tract cancer patients with a propensity towards improved outcomes and provide a chance for long term survival. The longer disease free interval between primary tumour and the liver metastases, response to the neoadjuvant treatment and other prognostic markers may also facilitate better selection of patients with more favourable tumour biology and prognosticate individual patient.
Publish Date 2018-08-15 10:07
Citation Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220
URL http://www.wjgnet.com/1948-5204/full/v10/i8/211.htm
DOI http://dx.doi.org/10.4251/wjgo.v10.i8.211
Full Article (PDF) WJGO-10-211.pdf
Full Article (Word) WJGO-10-211.doc